Skip to content

Clinical trials

Phase 3 Small Cell Lung Carcinoma trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Small Cell Lung Carcinoma Phase: Phase 3 Clear all

116 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20002
20013
20026
20031
20064
20074
20081
20091
20101
20112
20122
20132
20151
20163
20175
20187
20196
20205
20218
20225
20234
202411
202513
20268

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed46
Recruiting20
Active, not recruiting16
Unknown status12
Not yet recruiting9
Terminated9
Withdrawn4

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Amgen6
Alliance for Clinical Trials in Oncology5
Hoffmann-La Roche5
AbbVie4
AstraZeneca4
GlaxoSmithKline4
Merck Sharp & Dohme LLC3
Qilu Pharmaceutical Co., Ltd.3
Zai Lab (Shanghai) Co., Ltd.3
Bristol-Myers Squibb2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Small Cell Lung Carcinoma116
Lung Neoplasms22
Carcinoma, Non-Small-Cell Lung12
Neoplasms7
Breast Neoplasms6
Brain Neoplasms5
Prostatic Neoplasms4
Carcinoma, Small Cell3
Esophageal Neoplasms3
Neoplasm Metastasis3

Trials

Showing 76 to 100 of 116. Each trial links to its page on Pharma Observatory.

16 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.